CVE-2026-30573

Exploitation

Public exploit code exists. CISA's assessment records a public proof of concept. That is not a report of exploitation in the wild.

SSVC decision

• ExploitationpocPublic proof-of-concept exploit code exists. Not a report of exploitation in the wild.
• AutomatableyesAn attacker can reliably automate reconnaissance through exploitation, so this scales.
• Technical ImpactpartialSuccessful exploitation gives limited control of the vulnerable component.

CISA publishes the decision points, not a final SSVC decision. The decision also depends on mission and well-being impact, which is a property of your deployment rather than of the vulnerability.

EPSS probability

0.25% probability of exploitation activity in the next 30 days.

EPSS percentile

Ranks above 16.6% of scored records. A rank, not a probability.

NVD base score

7.5 (CVSS v3.x), scored by the NVD independently of the CNA.

NVD CVSS vector

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:H/A:N

NVD analysis status

Analyzed. NVD last modified this record on 2026-06-17.

Red Hat severity

No Red Hat rating. Red Hat rates the CVEs that affect its products.

Exploit-prediction scores from FIRST. Independent scoring and analysis status from the NVD. Vendor severity from Red Hat. Exploitation assessment and catalog membership from CISA.

Published

2026-04-01 00:00Z5 MO AGO

Last updated

2026-04-01 17:52Z5 MO AGO

Reserved

2026-03-04

Assigning CNA

mitre

Record state

PUBLISHED

Severity

High (CVSS 7.5)

CNA CVSS vector

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:H/A:N

Weaknesses

• CWE-1284Improper Validation of Specified Quantity in InputBase

Data version

5.2

Document digest

27e2d1aa48fbe0b7cf6ba354379f00f2975088527bed14530926b4c2df2b334c

• github.comhttps://github.com/meifukun/Web-Security-PoCs/blob/main/Pharmacy-Product-Management-System/Logic-AddSales-NegativePrice.md